Northern Trust’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.71M | Buy |
279,825
+6,356
| +2% | +$130K | ﹤0.01% | 2394 |
|
|
2025
Q1 | $5.47M | Sell |
273,469
-11,118
| -4% | -$223K | ﹤0.01% | 2372 |
|
|
2024
Q4 | $7.58M | Buy |
284,587
+22,657
| +9% | +$604K | ﹤0.01% | 2282 |
|
|
2024
Q3 | $7.47M | Buy |
261,930
+23,439
| +10% | +$668K | ﹤0.01% | 2239 |
|
|
2024
Q2 | $5.19M | Sell |
238,491
-5,897
| -2% | -$128K | ﹤0.01% | 2371 |
|
|
2024
Q1 | $5.41M | Sell |
244,388
-5,595
| -2% | -$124K | ﹤0.01% | 2396 |
|
|
2023
Q4 | $5.39M | Buy |
249,983
+6,137
| +3% | +$132K | ﹤0.01% | 2459 |
|
|
2023
Q3 | $4.12M | Buy |
243,846
+6,762
| +3% | +$114K | ﹤0.01% | 2559 |
|
|
2023
Q2 | $3.25M | Buy |
237,084
+11,382
| +5% | +$156K | ﹤0.01% | 2735 |
|
|
2023
Q1 | $5.13M | Sell |
225,702
-4,391
| -2% | -$99.8K | ﹤0.01% | 2458 |
|
|
2022
Q4 | $5.42M | Buy |
230,093
+2,625
| +1% | +$61.8K | ﹤0.01% | 2434 |
|
|
2022
Q3 | $5.93M | Buy |
227,468
+5,337
| +2% | +$139K | ﹤0.01% | 2362 |
|
|
2022
Q2 | $4.88M | Buy |
222,131
+9,806
| +5% | +$215K | ﹤0.01% | 2532 |
|
|
2022
Q1 | $9.53M | Sell |
212,325
-6,337
| -3% | -$284K | ﹤0.01% | 2169 |
|
|
2021
Q4 | $9.37M | Sell |
218,662
-4,933
| -2% | -$211K | ﹤0.01% | 2272 |
|
|
2021
Q3 | $14.9M | Buy |
223,595
+792
| +0.4% | +$52.7K | ﹤0.01% | 2003 |
|
|
2021
Q2 | $16.3M | Buy |
222,803
+45,829
| +26% | +$3.36M | ﹤0.01% | 2033 |
|
|
2021
Q1 | $12.1M | Buy |
176,974
+14,552
| +9% | +$996K | ﹤0.01% | 2175 |
|
|
2020
Q4 | $10.9M | Buy |
162,422
+8,117
| +5% | +$545K | ﹤0.01% | 2195 |
|
|
2020
Q3 | $7.94M | Buy |
154,305
+24,670
| +19% | +$1.27M | ﹤0.01% | 2250 |
|
|
2020
Q2 | $4.89M | Buy |
129,635
+21,593
| +20% | +$814K | ﹤0.01% | 2540 |
|
|
2020
Q1 | $3.22M | Buy |
108,042
+51,558
| +91% | +$1.54M | ﹤0.01% | 2569 |
|
|
2019
Q4 | $1.94M | Buy |
56,484
+5,287
| +10% | +$182K | ﹤0.01% | 3146 |
|
|
2019
Q3 | $926K | Buy |
+51,197
| New | +$926K | ﹤0.01% | 3413 |
|